IMCOR Pharmaceutical Co.

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

26 documents for IMCOR Pharmaceutical Co.

- IMCOR Pharmaceutical Co. Announces Departure of CFO.
SAN DIEGO -- IMCOR Pharmaceutical Co. (Pink Sheets:ICPH) (formerly known as Photogen Technologies, Inc.) announced today that Brooks Boveroux will be ...
- Business Wire
- September 27, 2004
- IMCOR Pharmaceutical Co. Reports Full Year 2003 Results.
Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--April 22, 2004 IMCOR Pharmaceutical Co. (Nasdaq:ICPHC) (formerly known as Phot...
- Business Wire
- April 22, 2004
- Research and Markets: IMCOR Pharmaceutical Co - Product Pipeline Report Now Available.
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c75525) has announced the addition of IMCOR Pharmaceutical Co - Pro...
- Business Wire
- November 28, 2007

- IMCOR Pharmaceutical Co. Appoints Jack DeFranco to Chief Operating Officer.
SAN DIEGO -- IMCOR Pharmaceutical Co. (PINK SHEETS:ICPH) announced the appointment of Jack DeFranco to Senior Vice President and Chief Operating Offic...
- Business Wire
- February 22, 2005
- IMCOR Pharmaceutical Co. Announces the Commencement of a Phase 2 Repeat Dosing Clinical Trial.
SAN DIEGO -- IMCOR Pharmaceutical Co. (OTC:ICPH), announced today that it has commenced a Phase 2 clinical study designed to investigate alternative m...
- Business Wire
- December 07, 2004
- IMCOR Pharmaceutical Co. Receives Commitments for $10 Million Equity Financing.
Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--April 14, 2004 IMCOR Pharmaceutical Co. (NASDAQ:ICPHC) (formerly known as Phot...
- Business Wire
- April 14, 2004
- IMCOR Pharmaceutical Co. Closes $2.0 Million Tranche of $10 Million Equity Financing.
Business Editors/Health/Medical Writers SAN DIEGO--(BUSINESS WIRE)--April 23, 2004 IMCOR Pharmaceutical Co. (Nasdaq: ICPHC) (formerly known as Pho...
- Business Wire
- April 23, 2004
- IMCOR Pharmaceutical Co. Ultrasound Contrast Agent Imagent Featured in Four Presentations at the RSNA in Chicago.
SAN DIEGO -- IMCOR Pharmaceutical Co. (Nasdaq:ICPHC) announced today that Dr. Ethan Halpern of Thomas Jefferson University Hospital presented the resu...
- Business Wire
- November 29, 2004
- IMCOR Pharmaceutical Co. Announces Reverse Split.
SAN DIEGO -- IMCOR Pharmaceutical Co. (PINK SHEETS:ICRP) announced today the effectiveness of a one-for-twenty reverse stock split of its common stock...
- Business Wire
- March 04, 2005
- IMCOR Pharmaceutical Co. Announces Appointment of New Auditors.
SAN DIEGO -- IMCOR Pharmaceutical Co. (PINK SHEETS:ICRP) announced today the engagement of Peterson & Co., LLP as its independent public accountants f...
- Business Wire
- March 22, 2005